Dynamic Technology Lab’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Dynamic Technology Lab’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,902	Closed	-$62K	–	1376
2018 Q3	$62K	Buy	+2,902	New	+$88.3K	0.01%	970
2018 Q1	–	Sell	-3,899	Closed	-$285K	–	1435
2017 Q4	$285K	Buy	3,899 +1,265	+48%	+$105K	0.05%	717
2017 Q3	$241K	Buy	+2,634	New	+$202K	0.04%	831
2015 Q4	–	Sell	-689	Closed	-$222K	–	1175
2015 Q3	$222K	Buy	+689	New	+$303K	0.08%	595

Other funds holding LUMO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dynamic Technology Lab's LUMO Position: Q4 2018 in Review

Dynamic Technology Lab sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2018, closing a stake of 2,902 shares — an estimated $62K sold.

Dynamic Technology Lab first reported a position in LUMO in Q3 2015 and held it in 4 quarters. The position peaked at $285K in Q4 2017. 87 funds tracked by Wall St. Rank hold LUMO as of Q4 2018.

Dynamic Technology Lab reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Dynamic Technology Lab sold 2,902 Lumos Pharma, Inc. Common Stock shares in Q4 2018, an estimated $62K.
Dynamic Technology Lab first reported a position in Lumos Pharma, Inc. Common Stock in Q3 2015 and held it in 4 quarters.
Dynamic Technology Lab's Lumos Pharma, Inc. Common Stock position peaked at $285K in Q4 2017.
87 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2018.

Based on Dynamic Technology Lab's 13F filing for Q4 2018, filed 13 Feb 2019.